Theravance Biopharma
TBPH
TBPH
98 hedge funds and large institutions have $793M invested in Theravance Biopharma in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 15 closing their positions.
Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
38
Reduced
21
Closed
15
Calls
$2.26M
Puts
$17.3M
Net Calls
-$15M
Net Calls Change
-$1.97M
Top Buyers
1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$7.54M |
2 |
![]()
2
Parallax Volatility Advisers
San Francisco,
California
|
$5.53M |
3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$3.61M |
4 |
JG
4
Jefferies Group
New York
|
$5.02M |
5 |
5
Nomura Holdings
Tokyo,
Japan
|
$3.56M |